Table 3. Factors that influence cycle cancellation in women with diminished ovarian reserve.
| Univariate | ||
|---|---|---|
| OR (95% CI) | P-value | |
| Age (yr) | 0.91 (0.83–1.0) | 0.042 |
| Serum AMH (ng/mL) | 0.28 (0.09–0.87) | 0.028 |
| Serum FSH (mIU/mL) | 1.05 (1.02–1.08) | 0.001 |
| Total AFC (n) | 0.81 (0.66–0.99) | 0.035 |
| Peak E2 (pg/mL) | 0.99 (0.99–1.0) | 0.002 |
| <200 | 13.0 (2.7–62.72) | 0.001 |
| ≥200 but <800 | 4.18 (1.39–12.54) | 0.011 |
| ≥800 | 1 | |
| COH protocol | ||
| GnRH agonist long | 0 (0–0) | 0.998 |
| Antagonist | 0.44 (0.09–2.28) | 0.330 |
| Ultrashort | 0.19 (0.03–1.43) | 0.107 |
| Soft stimulation | 0.62 (0.15–2.68) | 0.524 |
| GnRH agonist microflare | 0.28 (0.054–1.43) | 0.126 |
| Natural/modified natural | 1 | |
| Cause of diminished ovarian reserve | ||
| Aging | 1 | |
| Previous ovarian surgery | 0.81 (0.23–2.92) | 0.751 |
| Id iopathic and previous chemotherapy | 3.1 (1.16–7.8) | 0.023 |
OR, odds ratio; CI, confidence interval; AMH, anti-Müllerian hormone; FSH, follicle-stimulating hormone; AFC, antral follicle count; E2, estradiol; COH, controlled ovarian hyperstimulation; GnRH, gonadotropin releasing hormone; EMS, endometriosis.